Is Urogen Pharma Ltd (URGN) a Good Buy in the Healthcare Sector?

The 41 rating InvestorsObserver gives to Urogen Pharma Ltd (URGN) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 72 percent of stocks in the Healthcare sector, URGN’s 41 overall rating means the stock scores better than 41 of all stocks.

URGN has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on URGN!

See Full URGN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 41 means the stock is more attractive than 41 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Urogen Pharma Ltd Stock Today?

Urogen Pharma Ltd (URGN) stock is trading at $13.17 as of 10:20 AM on Monday, Nov 20, an increase of $0.71, or 5.7% from the previous closing price of $12.46. The stock has traded between $12.51 and $13.20 so far today. Volume today is low. So far 95,949 shares have traded compared to average volume of 256,237 shares. Click Here to get the full Stock Report for Urogen Pharma Ltd stock.